The latest news for pharma industry insiders.
A Closer Look Into the Role of Compounding Pharmacies
In this exclusive PC Podcast interview, Donald Prentiss, founder and CEO of Qualthera, explains the role that compounding pharmacies play in the pharmaceutical supply chain, how compounding pharmacies helped bridge the gap for patients in need of their medication (especially during the tirzepatide shortage), while dispelling the notion that commercialized and compounded drugs are competing with one another, what he believes needs to be done amid the various legal battles pertaining to GLP-1s that are currently taking place, the inspiration behind Qualthera, along with its objectives and more.
Panelists provide an overview of emerging therapies for progressive pulmonary fibrosis (PPF), highlighting the latest developments and potential treatment options.
RFK Jr. Says He’s Not Anti-Vaccine Ahead of Senate Hearings
Robert F. Kennedy Jr., President Donald Trump’s pick to head the Department of Health and Human Services, will tell senators this week that he is not “anti-vaccine or anti-industry.”
Pharmaceutical Regulatory Affairs Market Trends Analysis Report 2025-2030
The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider, By Service, By Category, By Indication, By Development Stage, By Company Size, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global pharmaceutical regulatory affairs market size is expected to reach USD 14.34 billion by 2030, registering a CAGR of 7.17% from 2025 to 2030.
Matt Farrell talks with Pharmaceutical Executive about changing HCP access and engagement, creating opportunities for customer centricity as the linchpin for success. Learn more about connecting sales, marketing, and medical teams for the future of HCP engagement. https://lnkd.in/eMPFmcBr
#pharmaceuticals #lifesciences
Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs